Hepatitis B

One-third of the world’s population has been infected with the hepatitis B virus. Most people experience only a short, mild disease, but a lifelong ‘chronic’ infection occurs in some people.


Hepatitis B puts people at risk of liver disease and cancer. Our hepatitis B research focuses on understanding how chronic infections occur, and how they can be cured.

Our hepatitis B research

Our researchers are investigating why the immune system cannot eliminate chronic hepatitis B infections. This is leading to new strategies to cure hepatitis B by stimulating immune clearance of the virus.

Sign up to our quarterly newsletter Illuminate

Find out about recent discoveries, community supporters and more.

Illuminate Winter 2024
View the current issue